0001683168-22-000276.txt : 20220114
0001683168-22-000276.hdr.sgml : 20220114
20220114203213
ACCESSION NUMBER: 0001683168-22-000276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220114
FILED AS OF DATE: 20220114
DATE AS OF CHANGE: 20220114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DVONCH JEROME J
CENTRAL INDEX KEY: 0001518735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 22533304
MAIL ADDRESS:
STREET 1: 12701 COMMONWEALTH DRIVE
STREET 2: SUITE 9
CITY: FORT MYERS
STATE: FL
ZIP: 33913
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 645 MOLLY LANE, SUITE 150
CITY: WOODSTOCK
STATE: GA
ZIP: 30189
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0306
4
2022-01-14
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001518735
DVONCH JEROME J
C/O SONOMA PHARMACEUTICALS, INC.
645 MOLLY LANE, SUITE 150
WOODSTOCK
GA
30189
0
1
0
0
Chief Financial Officer
Stock option (right to buy)
4.6
2022-01-14
4
A
0
30000
A
2032-01-14
Common stock
30000
57777
D
The options vest 10,000 options each on 07/14/2022, 07/14/2023, 07/14/2024 and or upon a change of control.
The options were awarded and granted to Mr. Dvonch for services performed.
/s/ Amy Trombly (Attorney in fact)
2022-01-14